Page 23

Inhaler Therapy for COPD-An individualised approach to inhaler selection

Inhaler Therapy for COPD An individualised approach to inhaler selection

Adherence and inhaler satisfaction together predict improved health outcomes for patients with chronic obstructive pulmonary disease (COPD). Assessment of a patient’s co-ordination and inspiratory flow patterns should guide selection of inhaler devices. Adherence and device technique should be assessed regularly and before changing a patient’s therapy. Patients should use only one type of device for all of their inhaled therapies, where possible.

Modern Medicine – Issue 2 2022

April 11, 2022 by Peter COPD

Meaningful Relief in Painful Diabetic Neuropathy

Neuropathic pain is often associated with diabetic peripheral neuropathy and is defined as pain initiated or caused by a primary lesion or dysfunction in the nervous system. Pregabalin is a firstline treatment in all major international guidelines on the management of painful diabetic neuropathy (pDPN). Treatment with pregabalin leads to a clinically meaningful improvement in pain scores, offers consistent relief of pain and has an acceptable tolerance level.

Modern Medicine – Issue 2 2022

April 11, 2022 by Peter Endocrinology

Resistant Hypertension-Updates, issues and approach to management

Successful management of poorly controlled hypertension requires careful distinction of true resistant hypertension from other causes such as poor adherence to hypertension medications, undiagnosed secondary hypertension and white-coat hypertension. An individualised approach that includes modifying lifestyle and diet and optimising pharmacotherapies is recommended for patients with suspected resistant hypertension.

Modern Medicine – Issue 2 2022

April 11, 2022 by Peter Hypertension

Getting to the Root of Acne with Topical Creams

Azelaic acid cream or gel is useful in the treatment of mild-to-moderate acne, with an efficacy comparable to that of tretinoin, benzoyl peroxide and topical erythromycin. It has a favourable safety profile; it is not teratogenic, is not associated with systemic adverse events or photodynamic reactions. It also exhibits excellent local tolerability and does not induce resistance in P. acnes.

Modern Medicine – Issue 2 2022

April 11, 2022 by Peter Dermatology

Topical Treatment’s Deep Action in Skin Infections

Skin infections represent an important public health issue and cost-driver. Additionally, chronic skin lesions are sometimes colonised by Gram-negative species. Topical therapies are a key component in the management of mild-to-moderate skin infections. In such cases, topical antibiotics may be preferable to systemic treatment, since they maximise the effective doses at the site of infection while minimising the systemic side effects of the drugs.

Modern Medicine – Issue 2 2022

April 11, 2022 by Peter Dermatology

When It’s Not Acne: Papule and Pustule-Associated Rosacea

Rosacea is a chronic disorder that predominantly affects the central areas of the face (nose, forehead, cheeks and chin). It is characterised by frequent flushing, persistent erythema and telangiectasia, and episodes of inflammation during which swelling, papules and pustules are evident. These symptoms are frequently accompanied by periocular inflammation and are sometimes associated with the later development of cutaneous swellings known as phymas.

Modern Medicine – Issue 2 2022

April 11, 2022 by Peter Dermatology

Neuroendocrine Tumours on the Rise, Eight-year Study Assesses GEP-NET Management Trends

An eight-year observational, multi-centre, registry study was undertaken to assess the incidence and regional trends in diagnosis, clinical management and outcome assessments of patients with gastroenteropancreatic neuroendocrine tumours (GEP-NET) in the Asia-Pacific region, the Middle East, Turkey and South Africa. The pancreas was the most commonly reported primary tumour site, with abdominal pain being the most commonly reported symptom. Surgery was the mostcommon initial treatment, followed by treatment with somatostatin analogues. This analysis highlighted the need for improvements in clinical practice to ensure better evaluation and treatment management.

Modern Medicine – Issue 2 2022

April 11, 2022 by Peter Oncology

Running a Profitable Healthcare Practice

With excellent patient outcomes and a solid reputation, Michael’s healthcare practice seemed to be thriving. As his practice grew, so did the time spent on managing the accompanying admin. He was spending so much energy on these functions that he couldn’t focus on improving treatment service for his patients.

Modern Medicine – Issue 2 2022

April 11, 2022 by Peter Technology

Health is About Treating the Whole Patient Not Just the Disease

In 1948, the World Health Organization defined the concept of health as follows: “A state of complete physical, mental and social well-being and not merely the absence of disease or infirmity” (WHO 2018). This definition suggests that the patient should be evaluated from a very broad perspective. However even today, it is still difficult to say that this is actually done, especially for the follow-up of chronic and complex illnesses.

Modern Medicine – Issue 2 2022

April 11, 2022 by Peter Ethics

Congress Planner 2022

Modern Medicine is proud to present our 2022 Medical Conference Planner in line with our mission to add value for our readers.

The Planner is a unique, comprehensive list, designed to be a one-stop tool for doctors, and people in the healthcare industry, to use while they plan the events they’d like to attend in the coming year.

With an exhaustively researched list of almost 100 medical conferences that are due to take place over the coming year, the Planner is a tool you can’t afford to be without.Modern Medicine magazine will include more information and updates on current events, on a monthly basis.

February 11, 2022 by Peter Uncategorized

Recent Posts